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This paper discusses an integrated approach to mental health studies on Financing of Illness (FoI) and health account-
ing, Cost of Illness (CoI) and Burden of Disease (BoD). In order to expand the mental health policies, the following are
suggested: (a) an international consensus on the standard scope, methods to collect and to analyse mental health data, as
well as to report comparative information; (b) mathematical models are also to be validated and tested in an integrated
approach, (c) a better knowledge transfer between clinicians and knowledge engineers, and between researchers and
policy makers to translate economic analysis into practice and health planning.
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Background
The disease burden estimates allocate two-fifths of life
with disability to mental health needs (WHO, 2000).
One in four visitors to the health systems exhibits an
untreated mental health need. In low per capita
income countries, resources devoted specifically to
mental health interventions embrace only around 1%
of the expenditure on health; in middle per capita
income countries the amount is also low (around
2.5%). Only a few high per capita income countries
spend at least 10% or more of their health dollar in
mental health disease (WHO, 2008a, b; Euro
Observer, 2009). Mental health care deserves special
attention due to the large uncovered needs, to the
lack of specialised skilled workforce and of financial
resources, as well as to the complexity of the care
delivery system, associated with the diversity of
needs, and an interface with social care. Many pro-
blems faced in mental health economics are central to
long-term care (LTC) for chronic medical conditions
or for persons with disabilities (Salvador-Carulla
et al. 2006). Mental health care thus constitutes a genu-
ine paradigm of integrative medicine, as already
pointed out decades ago (Eisenberg, 1973).
Expanded service coverage requires a performing
information system that sustains effective stewardship.
How should programme leaders mobilise and allocate
financial resources? Should policy makers direct men-
tal health towards market services, supported by sub-
sidies, price and product control, regulations and
sanctions? Which associated determinants facilitate
technical information for mental health experts, health
accountants and planning officers?
Two groups of analyses that are expected to contrib-
ute to capture the effort on mental services are:
(i) different methods to analyse the costs, and impacts
of alternatives, interventions or programmes,
endogenous to the interventions (cost consequence
and cost offset), as well as quasi-experimental or
experimental programmes (cost-effectiveness,
cost-utility and cost-benefit analyses);
(ii) top-down modelling reviews (Evers et al. 2007).
This note focuses on Health Financing of illness (FoI)
and accounting, Cost of Illness (CoI), and Burden of
Disease (BoD) and modelling studies. These analyses
provide information susceptible to contribute to health
planning and evidence-based management monitoring
and evaluation to initiate a diagnosis of the situation
and to guide priority setting, on resource allocation,
systemic reform, expenditure control and systemic sur-
veillance, major steps to intervene in the field.
Towards a monitoring information system
The mental health financing field lacks cumulated evi-
dence to analyse and to improve the current situation.
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Recent balance between demand and the desire
expressed almost everywhere to expand mental health’
population coverage and actual implementations, a
new momentum to ensure that health financing
planning contributes to generate and to the effective,
efficient, and equitable use of fresh resources (WHO,
2008a, b). Informed decisions require a monitoring
system that operates an early response to adjustments
needed, notably in an environment of such scarcity of
resources. Health information systems (HIS), including
its mental health component, should aim at a stan-
dardised baseline monitoring indicators, describing,
explaining, sustaining, planning, forecasting or
simulating:
– needs (including BoD studies),
– the financing, allocation and resource use in the field
(FoI and Health Accounts),
– the operation and coverage of interventions through
their outcomes (CoI).
The monitoring system for a huge reordering effort
involves an effective change in the coverage and in
the epidemiology of mental health, and requires a
cohesive approach that considers the process, outputs
and outcomes, which identifies the tracking indicators
following a reflection on relevant operational objec-
tives. The prerequisite of handling unsolved questions
in health economics information includes the existing
trend of a fragmented analysis and the adoption of
standardised content and methods. A complementary
effort might involve the dissemination of agreed classi-
fications, methodological guidelines and best practice
protocols.
Standardisation of the various tools includes the
level of applicability, at micro- or at meso-level, as
well as expected reporting practice relating to the econ-
omic and service context where these services and
interventions take place. A programme and interven-
tion are positioned within larger health organisations
and territories and do not operate in a vacuum
(Whitten & Adams, 2003). Filling this ‘geographical
vacuum’ contributes to understanding the economical
effects of interventions, the generalisation of results
and transfer of evidence to policy and planning. This
information is critical in itself and to understand any
other evidence in health economics. Territorial com-
parisons are particularly important in the European
Union for several reasons, mainly due to patient
mobility, health safety and harmonisation, as well as
for the eventual convergence of member states
towards an integrated health market. Cross-country
comparisons have been set up as a priority for the
analysis of health-care reforms and monitoring in
Europe (WHO, 1996).
Health financing, accounting and FoI analysis
Health financing focuses on the strategies to collect,
manage and allocate resources in the health-care sys-
tem to steer and to perform interventions, while ensur-
ing the quality of mental care, and their impact on
population and patients. Expenditure data are a prere-
quisite to understand, describe and foresee these pro-
cesses (see Table 1 above). Health-accounting studies
play a relevant role, either at organisation level
(Trogdon et al. 2007) or at national or international
level (Poullier & Hernandez, 2001; Thomson et al.
2009). To date, health-accounting analysis is con-
sidered to be the most comprehensive source of expen-
diture information for comparative purposes. The
main advantages of an accounting reporting system
apply also to Mental Health, as summarized in Table 1.
The ‘finance-of-illness’ studies display complemen-
tary information about the proportion of total health
expenditure attributed to a specific illness or of a
group of illnesses to facilitate comparisons across
population groups and are relevant for policy plan-
ning and allocation of resources. Expenditure is disag-
gregated by component, thus knowing their relative
importance; for example, to identify the contribution
of Pharmaceuticals in total expenditure of a health
condition, and to compare it internationally to adjust
planning. Moreover, financing can be studied longi-
tudinally in order to facilitate a better understanding
of the evolution of (for example) pharmaceutical
expenditure or the expenditure on residential care
with respect to ambulatory care, issues which in men-
tal health can indicate the development of deinstitutio-
nalisation. It also allows us to understand the path of
health expenditure within a system (e.g. public vs. pri-
vate provision) or across different systems (e.g. health,
social care and housing systems). Looking across sys-
tems is especially important in view of the often wide-
ranging impacts of mental health problems, and
because of differences between systems in relation to
financing structure, incentives, eligibility and allo-
cation. In summary, FoI studies contribute to handle
barriers and incentives for the development of care
and health policy (McDaid et al. 2006).
Challenges of FoI
Few countries prepare HA on a continuous basis.
Standard methods are not implemented and the meta-
data lack the detail required for apprehending their
content; thus, the final estimates at the country level
show huge disparities; international comparisons are
virtually meaningless in some classes. Current oper-
ational disparities in setting boundaries relate, for
instance, to social care linked to Long-Term Care
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(LTC), which affects the comparability on the share to
mental health spending. Indicators on inpatient and
outpatient care are in practice not standardized in
their content. Moreover, the preventive–curative split
is not reliable as a comparative measurement to be
applied to mental health numerators. As it happens,
in evidence-based medicine, quality ratings should be
developed to enhance like-with-like comparisons.
The sources of information of the tools under discus-
sion are related to their underlying classifications. In
mental health, there is no single class collating all the rel-
evant contents and there is not yet a consensus on one
standard reporting format to reach full comparability
of the study results. For example, some studies aggre-
gate bipolar disorders and depression, whilst other
studies aggregate anxiety disorders and depression
whereas they exclude bipolar disorders from the grop-
ing. The Global Burden of Disease study (GBD) aggre-
gates the International Classification of Diseases
(ICD-10) codes in major classes or parent categories.
Dementia and Alzheimer appear in different groups of
diseases at ICD-10, while GBD includes both in the
same group and allows for a better measurement of
the mental health burden. Mental health conditions
are frequently chronic and related to LTC due to their
disabilities. The usual measurement strategy involving
‘value = price × quantity’ has to be adjusted to the degree
of dependency in LTC quantity. A similar case for
inpatient care involves length of stay to handle a pack-
age of services consumed by day.
The extent to which disability and interventions
should be covered in the costing and expenditure
measurement varies also among studies, as well as the
data sources and methods used in the estimates. Due
to lack of appropriate records to measure disease and
program interventions, specific resources at the level
of detail required, cost and spending data are mixed.
Cost and expenditure are sometimes understood as
complementary concepts, equivalent or being one part
of the other, pending on the level of analysis, e.g. expen-
diture is part of social cost but at micro level cost reflects
the value of resources expected to be used whereas
spending reflects real amounts channelled to purchase
services or inputs to produce them. Some costs are not
spending and vice versa. Mixture of approaches may
require specific adjustments based on the content of
the data at hand. Reporting complexities are also
involved as providers and financing funds may change
according to the type of beneficiary. The criteria to
measure costs and expenditure are not standard and
face feasibility problems. More explicit conceptual and
methodological guidelines to measure and to report
are to be promoted.
Measurement problems identified at country level
are even larger when estimates refer to a single
group of health conditions, such as mental disorders.
Table 1. Potential uses of mental health accounts
Axes under study Use of information
General Monitoring and evaluation of interventions
Identification of financing intervention areas
Design and simulation of appropriate interventions
Financing – Resource generation
Revenue collection
Fund pooling/mobilisation
Purchasing arrangements
– Resource spending
Effective consumption strategies
Allocative decisions
Distributive policies
Provision Volume, composition and pricing of services supplied
Characteristics of provider setting
For example hospital based/ambulatory and community/home based
Accountability of inputs and production factors (e.g. human resources on health, pharmaceuticals)
Inappropriateness, waste, economies of scale, efficiency gains
Consumption Balanced satisfaction of beneficiaries
Nature of services consumed anticipation (e.g. preventive/curative (including incentives))
Consumption by disease and population groups
Indicator linkages Equity, effectiveness, efficiency, sustainability, productivity, decentralization,
resource allocation, prices
Source: Adapted from Poullier & Hernandez (2001).
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The disparities show up in the accuracy and in the
meaning of the information provided; for example,
regarding the mental health share in European
countries of total public health expenditure
(European Commission, 2005), as well as worldwide
(Saxena, 2003). Problems on comparability of expendi-
ture have been described while testing the first propo-
sal of a standardised manual on health expenditure
(Orosz & Morgan, 2004). A revision on what to
measure and how to measure it has been initiated by
Eurostat, OECD and WHO and is expected by mid
2011 (OECD, 2009), which will include classifications
and guidelines, as well as recommendations on how
to measure expenditure by disease.
It may be also convenient to differentiate ‘frame’
financing studies from accounting analyses. The pur-
pose of frame studies is advocacy, they are frequently
based on existing estimates not fully standardised, to
profile a health policy. Health planning and monitor-
ing require actual financing studies to guide evidence-
based decision making.
Cost-of-illness analysis
It aims to quantify in monetary units health and non-
health resources related to a health condition, includ-
ing the impacts on non-service parts of the economy
(such as lost productivity and unpaid time of family
carers). This approach adopts a broader perspective
than expenditure, in particular through its inclusion
of the opportunity costs of non-marketed items. The
information provided is linked to prevalence estimates
(or, less commonly, incidence estimates), which adopt
a societal perspective with insights into the distri-
bution and the use of resources and their associated
costs across all relevant sectors (e.g. employment, jus-
tice, education, special accommodation, among
others). In addition, the distribution of direct and
indirect costs across different illnesses or groups of ill-
nesses can be analysed, which allows exploration from
a different perspective of the total cost distribution
(e.g. the proportion of the total cost attributable to
psychopharmaceuticals). It is widely accepted that
cost-of-illness studies from a societal perspective and
prevalence-based design are indispensable for
evidence-based health decision making (Saxena, 2003;
Hu, 2006; Trogdon et al. 2007).
In spite of its long history dating from mid 1960s
(Rice, 1996), the usefulness of CoI studies have been
contested, as these studies ‘may not have a clear econ-
omic meaning’, as ‘by focusing on health sector spend-
ing and lost labour productivity only, CoI studies
provide only a very partial picture of the true macroe-
conomic impact of disease, and fail to consider the
contribution of depleted capital accumulation, invest-
ment in human capital and demographic change to
diminished economic growth’. A more general and
dynamic assessment of forgone consumption opportu-
nities was recently recommended (WHO, 2009;
Chisholm et al. 2010). However, the problem of data
comparability is frequently ignored and overrated the
usability of CoI for territorial comparisons at macro-
and meso-level, by not taking into account the differ-
ent types of analysis listed above and the existing
links between macro- and microeconomics in the
analysis of health care. The low quality of international
CoI studies in mental health (Andlin-Sobocki et al.
2005) and its extensive use in the literature is
contradictory.
Modelling in mental health-care (MH) financing
The development of models of MH financing and
related areas may contribute to overcome some of
the challenges described above. In addition to math-
ematical models, expert-based modelling plays a rel-
evant role in financing, cost control and analysis of
incentives and barriers at the three levels in Europe
(national, regional and local).
Expert-based modelling
Mental health-care systems and networks are extra-
ordinarily complex even at a programme level (Byng
et al. 2008). The arrangements of mental health vary,
not only from country to country but also across
small health areas within a single region. The Mental
Health Economics European Network (MHEEN-II)
study provided examples of this geographical variabil-
ity and on the difficulty of setting up international
comparisons in very simple indicators such as the
share of mental health expenditure in relation to the
total public expenditure in health (Knapp et al. 2008).
In order to facilitate international comparisons on
financing, cost control strategies, equity, parity, effec-
tiveness and quality of care, it is necessary to provide
a definition and a model of care, which may be com-
pared across territories. For example, it should be
decided as to whether social services will be included
in the model, specialised services for drug abuse, child
and adolescent mental health, psychogeriatrics, or ser-
vices for persons with intellectual disabilities and men-
tal health problems. These inclusion and exclusion
criteria are necessary as some countries include drug
addiction services as a category for funding and pro-
vision, which is separated from MH, while services
for dementia may be included in the MH chapter of
health expenditures, and there is no standard
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recording system for LTC and the various social care
services related. However, half of the interventions
are social and hardly should be left out. Therefore,
exclusion and inclusion criteria should be agreed and
a basic care model should be described to enhance
meaningful international comparisons. As an example,
a basic mental health community care (B-MHCC)
model was defined by experts in order to rate the effi-
ciency and appropriateness of a sample of small men-
tal health areas in different regions (autonomous
communities) in Spain (Salvador-Carulla et al. 2007).
This model comprises a reduced set of 12 input and
output indicators of residential and day care that pro-
vide an appraisal of the mental health care at area
level. It was applied in Chile to compare service pro-
vision in Chile and Spain, also at small health area
level (Salvador-Carulla et al. 2008). Expert-based
models of the processes of care have been used to esti-
mate activity based costing (ABC) of mental health
care in Navarra (Spain) (Moreno et al. 2008).
Financial flows should also be modelled to gauge
funding and financing of the health systems.
Mathematical modelling
WHO has recently provided a frame of modelling
strategies to capture the different consequences of dis-
ease guided by the question that is being asked. The
methodological approaches are divided into six mod-
elling types taking into account whether the focus is
provided on microeconomics or macroeconomics,
and whether non-market losses are included or not
(WHO, 2009). These models include: (1) inter-temporal
choice models (using output-based approach to
measure losses); (2) willingness-to-pay valuation tech-
niques; (3) simulation-based computable general equi-
librium models; (4) simulation-based calibration
models; (5) regression-based growth models; and (6)
full-income models using estimated value of statistical
life (VSL) to years lost due to disease or injury. The
WHO report recommends that empirically based esti-
mates of market losses and hypothetically based esti-
mates of foregone welfare be separately identified
and reported.
The efficiency and financing in mental health care
could also be explored using regression or Bayesian
multilevel analysis, knowledge discovery from data
(KDD) and data envelopment analysis (DEA)
(Salvador-Carulla et al. 2006). As an example, there is
extensive literature about the efficiency of a set of hos-
pitals or other health services using different model
techniques, mainly ordinary least square (OLS)
regression models, fixed-effect models and DEA.
While OLS tend to show that hospitals with more
staff have better outcomes, fixed-effect models greatly
reduce potential omitted variable bias, by incorporat-
ing hospital dummies in the regression that would
control for observable and unobservable differences
in other factors across hospitals. On the other hand,
DEA is a non-parametric method used to inform on
the relative efficiency of care systems in different terri-
tories including both regional and health small areas
such as primary care areas or community mental
health areas (Salvador-Carulla et al. 2007). DEA model-
ling can be run with different inputs and outputs; it is
not necessary to test a relationship function between
parameters and it does not depend on the scale of
analysis. Unfortunately, great disparities may be
found between DEA results applied to the same set
of data mainly due to different approximations to the
framework defined by the expert knowledge, interfer-
ences in the information transfer between clinicians
and operations analysts, the discretionary selection of
input and output parameters when the number of
units of analysis is small, the different modelling pro-
cedures that can be used, and the uncertainty derived
from lack of data on the validity and reliability of the
DEA model. These problems may be solved by com-
bining Monte Carlo and DEA and by incorporating
implicit knowledge of the experts into the model.
Apart from analysis of territories (countries, regions
or local areas), modelling could be applied to estimate
unit costs under conditions of high uncertainty.
Fixed-effect models and Monte Carlo have been
suggested as alternatives for assessing costs across
territories.
It is also necessary to develop common standards
and guidelines on the use of modelling for mental
health-care financing and related analyses as well as
to design a standard approach to incorporate implicit
knowledge into the analysis of costs and financing in
mental health care. Furthermore, the increasing com-
plexity of these tools may widen the knowledge gap
between clinicians and knowledge engineers on the
one side, and between researchers and policy makers
on the other. Finding bridges across users, clinicians,
researchers, knowledge engineers and policy makers
is critical to translate economic analysis into practice
and health planning.
BoD analysis
BoD studies use a global morbidity–mortality indi-
cator and adjust life years according to disability or
quality of life for each illness. They measure, for
example, the number of years lived with disability or
impaired quality of life. They help establish a ‘classifi-
cation table’ of diseases and facilitate comparisons
within the health sector both at a national and
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international level. Health Utility Index, Health
Adjusted Life Years, Quality of Life Adjusted Life
Years and Disability Adjusted Life Years are different
measures that can be used in BoI as well as in
cost-utility analysis. The advantages and caveats of
every approach have been extensively analysed in
the literature (Gold et al. 2002; Ayuso-Mateos et al.
2006) and would not be treated here. The consideration
of the relevance of mental health needs displayed by
BoD measurements would certainly impact the
amount required for expenditure on health as well as
to guide allocation of resources, both national or
those linked to aid, key questions in all environments
(Health Affairs, 2007; Savedoff, 2007).
Consensus and knowledge base for Mental Health
studies in Europe
The European Commission funded the project Mental
Health Economics European Network (MHEEN)
which provides a useful experience on the caveats
and alternatives to improve current information pro-
blems for international comparison of mental health
financing in Europe (Knapp et al. 2008). MHEEN also
developed a basic standard system and terms for gath-
ering this information and constitute a useful
knowledge-base to facilitate information transfer in
Europe. A relevant outcome of this project was the
need to differentiate between a general and broad
description of the financing systems at country level
and specific studies on incentives/barriers or in the
comparability of cost control mechanisms in different
EU countries. A multi-level approach should be fol-
lowed completing information at national level,
regional level and, whenever possible at local or
small health area level. These three levels should
allow comparisons like-with-like. For example, it
may be feasible to compare Italy, France and Spain,
but Luxembourg could be also compared with smaller
territorial units (i.e. country regions). Also, indicators
in Luxembourg should consider the discrepancy on
population denominators due to commuters, for
which there are no standard adjustments rec-
ommended. Some agreement on the level of reporting
should also be reached. These conditions involve set-
ting and operating recommendations in the HIS.
On the other hand, putting together national and
regional data adds confusion to the health planner as
it hampers comparisons like-with-like. The WHO
Report on Policies and practices for mental health in
Europe is a good example of how complex territorial
comparison is in current Europe, and the little use of
showing in the same table information from the region
of Murcia (Spain), France or Russia (WHO, 2008).
Moreover, information at small health areas may pro-
vide bottom-up analysis of the health financing and
funding flows, providing relevant and complementary
information gathered at the national level using a
top-down approach.
MHEEN has also provided a frame analysis of the
current incentives and barriers of mental health finan-
cing as well as a first assessment of cost control tools in
mental health care in Europe (McDaid et al. 2006;
Knapp et al. 2007). To sum up, current cost control
tools such as Diagnostic Related Groups (DRGs)
show usability problems in mental health care. DRG
tariffs area geared to study short-term, acute episodes
and they are ill suited for chronic, repetitive uses.
DRGs are better suited for one off medical interven-
tion, not repeated ones, and better suited for disease
but not disabilities. Thus, they have not fully taken
into account all of the costs associated with chronic
mental health problems, and, in spite of further adjust-
ments in countries like Spain or Austria, they may do
little to tackle the continued under-funding of mental
health services (McDaid et al. 2006). As matter of
fact, DRGs have not only being criticised as being
inappropriate for reimbursement, but they also may
provide perverse incentives to reduce the quality of
care which may not appear at the point of discharge
but rather in the long run (Zechmeister & Osterle,
2006). Other alternatives such as the use of ABC in
Spain (Moreno et al. 2008), the Healthcare Resource
Groups (HRGs) in the UK (Mogyorosy & Smith,
2005) or the Secondary Classification – Psychiatry
(SK-PSYK) in Norway (Heurgren et al. 2004) need
further revision (Northcott & Llewellyn, 2004), particu-
larly in mental health care as well as additional studies
at the international level.
The need of a complementary use of the tools
As the MHEEN project suggests (Knapp et al. 2008),
there is room for many improvements in the measure-
ment field. In spite of the potential value of these tools,
there is a widespread recognition of the problems of
available data in mental health economics (Jones
et al. 2007), as well as the need for more information,
particularly with regard to international studies.
The different approaches to the economic context of
care interventions provide complementary information
to articulate evidence-based decision making. Data on
cost effectiveness may be of little use for policy
decision making unless it could be contextualised in
the territory, and placed within the broader context
of health expenditure, CoI and Burden of Illness
(BoI). BoD facilitates comparisons across different
health condition or disease groupings by using league
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tables or other ranking procedures to set up priorities
in allocation of resources and strategic planning. BoD
has played a crucial role in priority setting of mental
disorders at the country level and worldwide
(Murray & Lopez, 1996). Furthermore, financing and
CoI data are also needed in strategic care planning.
For example, total expenditure in antidepressants
may be a relevant indicator for cost control of the men-
tal health care, but this information should be comple-
mented with cost-of-illness information on the share of
use and costs of antidepressants for patients with
depression in contact with services in relation to the
total health direct costs and – when available – in
relation to total costs. The impact of a national pro-
gramme on prevention of suicide should be analysed
both from the financing perspective and from the CoI
perspective. CoI may indicate, for example, that mor-
tality costs related to suicide are in a given country
at the bottom line of Europe, while morbidity costs
related to employment disability benefits are at the
highest rate. This information may be critical to allo-
cate a new seed funding in programmes for the pre-
vention of suicide, in programmes for promotion of
mental health at the workplace, or in improving the
assessment of work-related disabilities.
When a single approach is followed (either FoI, CoI
or BoD) a partial description is provided and the final
information may not only be incomplete but also
misleading. Data on financing could be aggregated to
CoI data and vice versa, providing imprecise estimate
of both costs and expenditures. This is the case of
the report on costs of the health programmes in
Catalonia, which imputes expenditures of social and
health services for dementia and total costs of psycho-
tropic medication to the MH budget, and produces an
overestimate of the MH share of the total public health
expenditure in Catalonia (Spain) (Gisbert et al. 2007).
The steps forward
In order to advance the monitoring system, a series of
alternatives come into view.
First, there is an urgent need for reaching inter-
national standard to collect and to compare quantitat-
ive economic information. Consensus should initiate
by setting the scope of the mental health field, as to
which entities include, how to deal with the associated
social services and what non-health services to con-
sider. Measurement strategies should indicate the var-
ious relevant reporting layers to compare at national
and international levels. There are plenty of national
and international guidelines for the cost analysis of
pharmaceuticals and, hence, international standards
are available for any study on cost of alternatives.
However, financing, accounting and CoI studies use
a wide range of methods and rules to aggregate data
and it is nearly impossible to make any comparison
across studies even within a single country, at the
required disaggregate information level by disease.
Second, the methods developed to date for service
classification and for standard unit cost calculation
are complex, time-consuming, heterogeneous and
show feasibility problems. The Quatro study on adher-
ence of schizophrenia provides a clear example of
these caveats of unit cost calculation in international
studies (Patel, 2006). A genuine contribution is
required to ensure that mental health becomes feasible
on both an epidemiologically and financially monitor-
able entity.
Third, an explicit review on data collection gather-
ing and administrative records is suggested as feed-
back to the HIS to improve data sources. For
example, there is an urgent need to incorporate
Geographical Information Systems (GIS) and spatial
analysis to health financing in order to improve the
usability of the economic information in evidence-
based health care. Mental Health financing and health
accountability studies stress the importance of map-
ping services as a key part of the financing and the
accountability processes (WHO, 2003; WHO et al.
2003). On the other hand, cost-effectiveness studies
do not usually report characteristics of the area
where centres are located. Both socio-demographic
characteristics and service availability may influence
service use and related costs (Tibaldi et al. 2005). For
example, the availability of hospital care in one area
may have an influence on hospitalisation and ‘relapse’
rates of schizophrenia when ‘relapse’ is related to a
pattern of service use (Kane et al. 1998). Hence, both
direct and indirect costs may be significantly higher
in an area with bed availability far above the median,
than in another area without non-acute hospital care.
Fourth, a number of problems may contribute to a
systematic bias of measurement in health economic
studies and hamper comparisons like-with-like,
which should be handled on ad-hoc basis. The termino-
logical variance in service name and coding is a rel-
evant factor in service comparison both in health
economics and health financing studies (Zechmeister &
Osterle, 2006). The ICF service classification system
(WHO, 2001) is too imprecise to be used for account-
ability purposes. The International Classification of
Health Accounts (ICHA) (OECD, 2009), including
their Health providers and Health Functions com-
ponents have consistency problems and to avoid
overlaps and missing relevant content require
improvement during the current revision. Even then,
clinical practice variation may produce a different pat-
tern of activities in equivalent facilities (Gigantesco
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et al. 2007). Furthermore, the lack of a standard method
of unit cost calculation to translate service utilisation
into monetary units impedes reliable and valid cost
comparison across countries (Patel, 2006; Moreno
et al. 2008).
Conclusion
To improve evidence-based health planning, infor-
mation on BoD, CoI, FoI, health accounting and cost
control should be incorporated to more traditional
cost-of-alternatives (cost-effectiveness) data. This infor-
mation should be also combined and represented
using GIS. Mental health care poses similar challenges
due to the complexity and the peculiarities of this sec-
tor. Three critical aspects for adding these analyses to
conventional health economic data are (1) the develop-
ment of consensus-based guides, indicators and a stan-
dard organisation of the available information within a
common knowledge base format; (2) the incorporation
of modelling to the analysis of data on financing and
related issues; and (3) improve knowledge transfer
strategies across different stakeholders with regard to
health economic evidence.
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